Bowhead Specialty (NYSE:BOW) Price Target Raised to $44.00 at Keefe, Bruyette & Woods

Bowhead Specialty (NYSE:BOWGet Free Report) had its target price hoisted by research analysts at Keefe, Bruyette & Woods from $36.00 to $44.00 in a research note issued on Friday,Benzinga reports. The firm currently has a “market perform” rating on the stock. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 38.19% from the company’s current price.

A number of other equities research analysts have also recently commented on BOW. Royal Bank of Canada raised their price objective on shares of Bowhead Specialty from $32.00 to $35.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 6th. JPMorgan Chase & Co. lifted their price objective on shares of Bowhead Specialty from $26.00 to $30.00 and gave the company a “neutral” rating in a report on Thursday, November 7th. Finally, JMP Securities upped their price objective on shares of Bowhead Specialty from $32.00 to $33.00 and gave the stock a “market outperform” rating in a research report on Wednesday, November 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $33.60.

View Our Latest Report on Bowhead Specialty

Bowhead Specialty Trading Up 0.0 %

NYSE:BOW opened at $31.84 on Friday. Bowhead Specialty has a 12 month low of $22.14 and a 12 month high of $37.81. The firm has a fifty day simple moving average of $34.52 and a 200-day simple moving average of $30.44.

Bowhead Specialty (NYSE:BOWGet Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.38. The business had revenue of $116.76 million for the quarter, compared to analysts’ expectations of $113.00 million. On average, sell-side analysts predict that Bowhead Specialty will post 1.38 earnings per share for the current year.

Insider Transactions at Bowhead Specialty

In other Bowhead Specialty news, Director Family Mutual Insuran American sold 1,362,285 shares of the stock in a transaction that occurred on Friday, October 25th. The shares were sold at an average price of $27.70, for a total transaction of $37,735,294.50. Following the sale, the director now directly owns 4,700,761 shares in the company, valued at $130,211,079.70. This represents a 22.47 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the company. Point72 Asset Management L.P. purchased a new position in Bowhead Specialty in the second quarter valued at approximately $117,000. MetLife Investment Management LLC acquired a new position in shares of Bowhead Specialty in the 3rd quarter valued at $123,000. Sandia Investment Management LP purchased a new position in shares of Bowhead Specialty in the 2nd quarter valued at $127,000. New Vernon Investment Management LLC acquired a new stake in Bowhead Specialty during the 3rd quarter worth $127,000. Finally, Quantbot Technologies LP purchased a new stake in Bowhead Specialty in the third quarter valued at $157,000.

Bowhead Specialty Company Profile

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

See Also

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.